| Literature DB >> 33326609 |
Jingjing Zhu1, Stephanie A Smith-Warner2,3, Danxia Yu1, Xuehong Zhang2,3, William J Blot1, Yong-Bing Xiang4, Rashmi Sinha5, Yikyung Park6, Shoichiro Tsugane7, Emily White8, Woon-Puay Koh9,10, Sue K Park11, Norie Sawada12, Seiki Kanemura13, Yumi Sugawara13, Ichiro Tsuji13, Kim Robien14, Yasutake Tomata13, Keun-Young Yoo11, Jeongseon Kim15, Jian-Min Yuan16,17, Yu-Tang Gao4, Nathaniel Rothman5, DeAnn Lazovich18, Sarah K Abe12, Md Shafiur Rahman7,12, Erikka Loftfield5, Yumie Takata19, Xin Li20, Jung Eun Lee21, Eiko Saito22, Neal D Freedman5, Manami Inoue12, Qing Lan5, Walter C Willett2,3,23, Wei Zheng1, Xiao-Ou Shu1.
Abstract
Associations of coffee and tea consumption with lung cancer risk have been inconsistent, and most lung cancer cases investigated were smokers. Included in this study were over 1.1 million participants from 17 prospective cohorts. Cox regression analyses were conducted to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Potential effect modifications by sex, smoking, race, cancer subtype and coffee type were assessed. After a median 8.6 years of follow-up, 20 280 incident lung cancer cases were identified. Compared with noncoffee and nontea consumption, HRs (95% CIs) associated with exclusive coffee drinkers (≥2 cups/d) among current, former and never smokers were 1.30 (1.15-1.47), 1.49 (1.27-1.74) and 1.35 (1.15-1.58), respectively. Corresponding HRs for exclusive tea drinkers (≥2 cups/d) were 1.16 (1.02-1.32), 1.10 (0.92-1.32) and 1.37 (1.17-1.61). In general, the coffee and tea associations did not differ significantly by sex, race or histologic subtype. Our findings suggest that higher consumption of coffee or tea is associated with increased lung cancer risk. However, these findings should not be assumed to be causal because of the likelihood of residual confounding by smoking, including passive smoking, and change of coffee and tea consumption after study enrolment.Entities:
Year: 2020 PMID: 33326609 PMCID: PMC8460087 DOI: 10.1002/ijc.33445
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.316